Tabuk Pharmaceutical Manufacturing Company
Tabuk Pharmaceutical Manufacturing Company, commonly referred to as Tabuk Pharma, is a leading player in the pharmaceutical industry, headquartered in Saudi Arabia. Established in 1994, the company has made significant strides in the Middle East and North Africa (MENA) region, focusing on the development, manufacturing, and marketing of high-quality pharmaceutical products. Tabuk Pharma offers a diverse range of core products, including prescription medications, over-the-counter drugs, and specialised formulations, distinguished by their commitment to innovation and quality. The company has achieved notable milestones, positioning itself as a trusted name in healthcare, with a strong market presence and a reputation for excellence in pharmaceutical manufacturing.
DitchCarbon Score
How does Tabuk Pharmaceutical Manufacturing Company's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Tabuk Pharmaceutical Manufacturing Company's score of 29 is lower than 60% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Tabuk Pharmaceutical Manufacturing Company's reported carbon emissions
Tabuk Pharmaceutical Manufacturing Company, headquartered in Saudi Arabia, has made significant commitments towards achieving net-zero carbon emissions. Although specific emissions data for the most recent year is not available, the company has committed to long-term net-zero targets across all scopes, with a timeframe extending from 2023 to 2050. This commitment is part of their alignment with the Science Based Targets initiative (SBTi). As a current subsidiary of Astra Industrial Group Company, Tabuk Pharmaceuticals' climate initiatives are influenced by the broader corporate strategy. The company is actively working towards reducing its carbon footprint, although specific reduction targets have not been disclosed. Tabuk Pharmaceuticals is dedicated to sustainability within the pharmaceuticals, biotechnology, and life sciences sector, reflecting a growing trend among companies in the industry to prioritise climate action. Their commitment to net-zero emissions underscores their proactive approach to addressing climate change and contributing to a more sustainable future.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Tabuk Pharmaceutical Manufacturing Company is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
